Newsletter Subject

Is 'Wellness' Bad News for Healthcare?

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Sep 7, 2024 11:14 AM

Email Preheader Text

Weekly Review Saturday, September 07, 2024 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT

[MEDPAGE TODAY]( Weekly Review Saturday, September 07, 2024 [Is 'Wellness' Bad News for Healthcare?]( [$100M Botched Circumcision Case; Perry Trial Date Set; Euthanasia Doc Pleads Guilty]( [Surgeon Removed Liver Instead of Spleen, Family Says]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Elevating Treatment Selection and Sequencing in Multiple Myeloma: Personalized Decisions Through Lines of Therapy]( [Neffy Is About to Hit Shelves: Considerations for Prescribing]( [Afib Ablation Delivers in First Sham-Controlled Study]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [Emergency Medicine Doc Is Running for Congress]( CME SPOTLIGHT [Exploring HER2 Targeting: Transforming Treatment for Metastatic and Locally Advanced HER2+ Cancers]( [Tennessee Medical Board Refuses to Enforce New IMG Law]( [Up to 1 in 5 Dementia Cases May Be Attributable to Vision Impairment]( [Predicting COVID Outbreaks Via Wastewater; New Medicine for Menopause]( CME SPOTLIGHT [Optimizing Infusion Therapies to Advance Care in Metastatic HR+/HER2- and Triple-Negative Breast Cancer]( [$300M Lawsuit for Hospital Where RN Is Accused of Replacing Fentanyl With Tap Water]( [The Widowmaker: Clarifying the Record for Our Patients]( [Feds Killed Plan to Curb Medicare Advantage Overbilling After Industry Opposition]( CME SPOTLIGHT [Updated Treatment Paradigms in HER2+ Breast Cancer]( [Residents Strike, Demonstrate Around Labor Day Weekend]( [More ADHD Drug Production; Psilocybin vs Lexapro; Addiction a Chronic Brain Disease?]( [RN Jobs That Won't Make You Hate Your Life; RSV Returns; Supplement Misinfo Spreads]( CME SPOTLIGHT [Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care]( [Insurer Will Launch 'Gold Card' Program to Skip Prior Authorization]( [RSV Vaccines Show High Effectiveness Against Hospitalization in Older Adults]( [Pause or Keep RAS Inhibitors Before Surgery? Take Your Pick.]( CME SPOTLIGHT [Breakthrough Immunotherapies Transforming Early-Stage NSCLC Treatment]( [Baby in Gaza Has Polio Strain Tied to Mistakes in Eradication Campaign, Experts Say]( [No Cellphone, Brain Cancer Link; Testosterone Paradox; Breast Density and Cancer]( [Brain Clock Disparities; How Morphine Relieves Pain; Tolebrutinib and MS Disability]( CME SPOTLIGHT [Optimizing Use of PARP Inhibitors in Early-Stage and Metastatic Breast Cancer Patients With DNA Damage Repair Pathway Mutations]( [PA Group Sends Second Letter Asking AMA for Policy Truce]( [Upper GI Damage Tied to Subsequent Parkinson's Disease]( [Physician Who Punched Officer During Capitol Riot Sentenced to Prison]( CME SPOTLIGHT [Changing Inertia in Chronic Myeloid Leukemia Management: Key Strategies From Leading Experts]( ['There’s Nothing in Law. There is Only Tradition': What We Heard This Week]( [With Only Gloves to Protect Them, Farmworkers Say They Tend Sick Cows Amid Bird Flu]( [DOAC Monotherapy Bests Dual Antithrombotic Therapy for Afib Plus Coronary Disease]( [Are You Ready for Wildfire Season?]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2024-09-07&mh=3c4cdd242849aa0e970f25e401732f81) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.